Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for uremic pruritus in hemodialysis patients (phase 2, dose-ranging, placebo-controlled)
2009-010437-50Phase 2Completed
- Sponsor
- Santa Maria Nuova
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gabapentin in chronic kidney disease-associated pruritus (CKD-aP) (3 arms), sponsored by Santa Maria Nuova. Primary endpoint: Change in itch severity (VAS pruritus score). Started Mar 2009; status: completed.
02
Drugs
gabapentin
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on 2009-010437-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010437-50.